Christian Martin Seitz

This study shows that using multiple adapter molecules in AdCAR-T cells can effectively target antigen-heterogeneous lymphoma by overcoming antigen-negative relapse.

This paper introduces cysteine-engineered CAR-T cells that target both conventional antigens and altered redox states in B cell lymphoma, reducing the risk of antigen escape.

This study shows that modified hCFTR mRNA delivered as nanoparticles improves lung function in a mouse model of cystic fibrosis.